|
|
|
|
|
|
|
|
132nd MAINE LEGISLATURE |
|
|
LD 697 |
|
LR 293(02) |
|
|
|
An Act to Direct
the Maine Prescription Drug Affordability Board to Assess Strategies to
Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based
Pricing |
|
Fiscal Note for
Bill as Amended by Committee Amendment " " |
|
Committee: Health Coverage, Insurance and
Financial Services |
|
Fiscal Note Required: Yes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Note |
|
|
|
|
|
|
|
|
|
|
FY 2025-26 |
FY 2026-27 |
Projections FY 2027-28 |
Projections FY 2028-29 |
Net Cost
(Savings) |
|
|
|
|
|
|
General Fund |
|
$223,422 |
$298,362 |
$311,162 |
$321,582 |
|
|
|
|
|
|
|
Appropriations/Allocations |
|
|
|
|
|
|
General Fund |
|
$223,422 |
$298,362 |
$311,162 |
$321,582 |
|
|
|
|
|
|
|
Fiscal Detail
and Notes |
|
|
|
|
|
|
This bill
includes ongoing General Fund appropriations of $223,422 in fiscal year
2025-26 and $298,362 in fiscal year 2026-27 to the Office of Affordable Heath
Care for one Public Service Manager III position, one Comprehensive Health
Planner II position, and related All Other costs to support the Prescription
Drug Affordability Board with strategic direction, administrative work, and
subscriptions and contracts to be used to obtain commercial drug pricing data
and for consulting services to support data analysis effective October 1,
2025. |
|
|
|
|
|
|
|